Drug Description in Trials / DrugBank / KEGG DRUG /

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1AAV BBP-631----[1] 81
2Abiraterone[1] Abiraterone---[2] 75, 81
3Abiraterone Acetate[2] Abiraterone,
Acetate		---[2] 75, 81
4Acetate[1] Acetate---[41] 1, 2, 6, 10, 13, 46, 49, 51, 60, 64, 67, 70, 71, 73, 75, 76, 78, 79, 81, 83, 85, 86, 88, 90, 96, 97, 113, 145, 156, 171, 206, 222, 224, 225, 227, 235, 251, 265, 288, 298, 299
5ATR-101----[2] 75, 81
6Balance[1] Isoxaflutole---[5] 6, 11, 46, 81, 149
7Bone balance measurements[1] Isoxaflutole---[1] 81
8Chronocort----[1] 81
9Chronocort 10mg----[1] 81
10Chronocort 5mg----[1] 81
11Chronocort®----[1] 81
12Chronocort® 10 mg----[1] 81
13Chronocort® 20 mg----[1] 81
14Chronocort® 5 mg----[1] 81
15CI-984, 17AA70, PD 132301-2----[1] 81
16Conventional Glucocorticoids (immediate release hydrocortisone, cortisone acetate, prednisone, prednisolone, dexamethasone)[7] Acetate,
Cortisone,
Cortisone acetate,
Dexamethasone,
Hydrocortisone,
Prednisolone,
Prednisone		[6] D00088 ,
D00292 ,
D00472 ,
D00473 ,
D00973 ,
D07749 		[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 81
17Cortef[1] Hydrocortisone cypionate[1] D00976 [1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[3] 6, 81, 83
18Corticotropin[1] Corticotropin[1] D00146 [1] MC2R 💬[5] Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[7] 2, 13, 46, 75, 81, 84, 222
19Cortisol[1] Hydrocortisone[1] D00088 [1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 81
20Cortison----[1] 81
21Cortisone[1] Hydrocortisone[1] D00088 [1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 81
22Cortisone acetate[3] Acetate,
Cortisone acetate,
Hydrocortisone		[2] D00088 ,
D00973 		[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 81
23Crinecerfont----[1] 81
24Crinecerfont is a novel non-peptide selective corticotropin releasing factor 1 (CRF1 ) receptor antagonist.[1] Corticotropin[1] D00146 [1] MC2R 💬[5] Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 81
25Dectancyl----[1] 81
26Dexamethasone[1] Dexamethasone[1] D00292 [1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[22] 13, 14, 16, 28, 35, 46, 53, 63, 64, 65, 70, 81, 84, 96, 97, 162, 222, 235, 257, 283, 296, 299
27Dexamethasone 0,1 mg Tablets[1] Dexamethasone[1] D00292 [1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 81
28Dexamethasone 0.5mg Tablet[1] Dexamethasone[1] D00292 [1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 81
29Dexamethasone 1,5 mg Tablets[1] Dexamethasone[1] D00292 [1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 81
30Dexamethasone 2mg Tablets[1] Dexamethasone[1] D00292 [1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 81
31DIURF-006----[1] 81
32Dual release hydrocortisone (plenadren)[1] Hydrocortisone[1] D00088 [1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 81
33Efmody 10 mg modified release hard capsules[2] Hydrocortisone,
Manganese citrate		[1] D00088 [1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 81
34Efmody 5 mg modified release hard capsules[2] Hydrocortisone,
Manganese citrate		[1] D00088 [1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 81
35Fludrocortisone[1] Fludrocortisone[1] D07967 [1] NR3C2 💬[1] Aldosterone-regulated sodium reabsorption 💬[3] 6, 17, 81
36Flutamide[1] Flutamide[1] D00586 [1] AR 💬[4] Chemical carcinogenesis - receptor activation, Oocyte meiosis, Pathways in cancer, Prostate cancer 💬[1] 81
37Hormonal balance measurements[1] Isoxaflutole---[1] 81
38Hydrocortisone[1] Hydrocortisone[1] D00088 [1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[10] 6, 41, 46, 53, 75, 78, 81, 83, 97, 299
39Hydrocortisone (Solucortef)[1] Hydrocortisone[1] D00088 [1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 81
40Hydrocortisone 10mg Tablet[1] Hydrocortisone[1] D00088 [1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 81
41Hydrocortisone 10mg Tablets[1] Hydrocortisone[1] D00088 [1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 81
42Hydrocortisone 20mg Tablets[1] Hydrocortisone[1] D00088 [1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 81
43HYDROCORTISONE MICRONIZED[1] Hydrocortisone[1] D00088 [1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 81
44Hydrocortisone Modified Release Capsules[1] Hydrocortisone[1] D00088 [1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 81
45Hydrocortisone sodium acetate[3] Acetate,
Hydrocortisone,
Sodium acetate		[2] D00088 ,
D01779 		[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 81
46HYDROCORTISONE SODIUM PHOSPHATE[2] Hydrocortisone,
Phosphate ion		[1] D00088 [1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[3] 53, 81, 83
47HYDROCORTISONE SODIUM SUCCINATE[1] Hydrocortisone[1] D00088 [1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[3] 81, 83, 97
48Hydrocortisone tablet 2.5 mg[1] Hydrocortisone[1] D00088 [1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 81
49HYDROCORTISONE- hydrocortisone tablet[1] Hydrocortisone[1] D00088 [1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 81
50IDROCORTISONE----[1] 81
51Infacort----[1] 81
52Infacort®----[1] 81
53Letrozole[1] Letrozole[1] D00964 [1] CYP19A1 💬[3] Metabolic pathways, Ovarian steroidogenesis, Steroid hormone biosynthesis 💬[2] 81, 89
54Lu AG13909----[1] 81
55Metabolic balance measurements[1] Isoxaflutole---[1] 81
56Metformin[1] Metformin[1] D04966 [2] PRKAA1,
PRKAA2 💬		[20] AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬[25] 2, 6, 8, 13, 46, 49, 60, 65, 67, 75, 77, 81, 86, 97, 113, 127, 158, 206, 218, 225, 233, 265, 285, 299, 301
57METFORMIN HYDROCHLORIDE[1] Metformin[1] D04966 [2] PRKAA1,
PRKAA2 💬		[20] AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬[5] 81, 158, 265, 299, 301
58Metformine[1] Metformin[1] D04966 [2] PRKAA1,
PRKAA2 💬		[20] AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬[3] 46, 81, 299
59Metformine Sandoz 850 mg filmomhulde tabletten[1] Metformin[1] D04966 [2] PRKAA1,
PRKAA2 💬		[20] AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬[1] 81
60MONITOR[1] Methamidophos---[4] 2, 11, 81, 129
61National Drug Code: 59762-0074----[1] 81
62NBI-74788----[1] 81
63NBI-77860----[1] 81
64Nevanimibe[1] Nevanimibe[1] D11300 --[2] 75, 81
65Nevanimibe hydrochloride[1] Nevanimibe[1] D11300 --[2] 75, 81
66Nifedipine[1] Nifedipine[1] D00437 [4] CACNA1C,
CACNA1D,
CACNA1F,
CACNA1S 💬		[37] Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[2] 50, 81
67Phosphate[1] Phosphate ion---[32] 2, 3, 6, 11, 12, 13, 28, 36, 46, 49, 51, 53, 60, 62, 65, 70, 78, 81, 83, 90, 96, 97, 164, 235, 238, 256, 276, 283, 284, 285, 286, 299
68Pioglitazone[1] Pioglitazone[1] D08378 [1] PPARG 💬[11] AMPK signaling pathway, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬[17] 2, 6, 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299
69PREDNISOLONE[1] Prednisolone[1] D00472 [1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[42] 3, 11, 13, 14, 25, 26, 35, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 56, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 107, 113, 145, 162, 222, 269, 271, 296, 299, 300
70Prednisolone 1mg Tablets[1] Prednisolone[1] D00472 [1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 81
71Prednisolone 2,5 mg Tablets[1] Prednisolone[1] D00472 [1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 81
72Prednisolone 5 mg Tablets[1] Prednisolone[1] D00472 [1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 81
73Prednisolone 5mg Tablet[1] Prednisolone[1] D00472 [1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 81
74Prednisone[1] Prednisone[1] D00473 [1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[45] 2, 11, 13, 14, 19, 26, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 61, 63, 64, 65, 66, 79, 81, 84, 85, 86, 95, 96, 97, 113, 162, 164, 205, 222, 224, 228, 283, 284, 288, 299, 300, 307, 331
75Release[1] Manganese citrate---[12] 6, 8, 13, 46, 65, 78, 81, 96, 97, 206, 226, 299
76Sodium acetate[2] Acetate,
Sodium acetate		[1] D01779 --[2] 81, 251
77Solu-Cortef[2] Hydrocortisone cypionate,
Hydrocortisone succinate		[2] D00976 ,
D01442 		[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[3] 6, 81, 83
78SPR001----[1] 81
79Standard Care----[2] 81, 299
80Standard glucocorticoid therapy----[1] 81
81TILDACERFONT----[1] 81